Analysis of websites containing brintellixhcp.com backlinks
These websites are/were linking to brintellixhcp.com.
Websites found: 6
Number of websited displayed: 6
List of results:
Takeda Pharmaceuticals U.S.A., Inc.http://site-overview.com/stats/takeda.us
- Website Address renewal date: 12/2/28
- Domain Address Reg. date: 08/9/18
- Website address in use until: 17/9/18
Takeda Pharmaceuticals U.S.A., Inc.http://site-overview.com/stats/tpna.com
- Website Address renewal date: 16/9/20
- Domain Address Reg. date: 01/11/19
- Website address in use until: 17/11/19
Takeda Pharmaceuticals U.S.A., Inc.http://site-overview.com/stats/tap.com
- Website Address renewal date: 17/8/9
- Domain Address Reg. date: 94/4/5
- Website address in use until: 18/4/6
Takeda Pharmaceuticals U.S.A., Inc.http://site-overview.com/stats/takedapharm.com
- Website Address renewal date: 17/5/15
- Domain Address Reg. date: 98/10/19
- Website address in use until: 18/10/18
Home | TRINTELLIX (vortioxetine)http://site-overview.com/stats/brintellixhcp.com
TRINTELLIX (vortioxetine) is indicated for the treatment of major depressive disorder in adults. WARNING: SUICIDAL THOUGHTS AND BEHAVIORS. Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies. These studies did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in patients over age 24; there was a trend toward reduced risk with antidepressant use in patients aged 65 and older. In patients of all ages who are started on antidepressant therapy, monitor closely for worsening, and for emergence of suicidal thoughts and behaviors. Advise families and caregivers of the need for close observation and communication with the prescriber. TRINTELLIX has not been evaluated for use in pediatric patients.
- Google Analytics ID: 35252106-2
- Website Address renewal date: 17/8/9
- Domain Address Reg. date: 13/6/17
- Website address in use until: 18/6/17